Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization

ACS Applied Materials and Interfaces

Volumn 8, Issue 22, 2016, Pages 13804-13811

  Fan, Jing ^a,b,d   He, Qianjun ^c   Liu, Yi ^b   Zhang, Fuwu ^b   Yang, Xiangyu ^a,b   Wang, Zhe ^b   Lu, Nan ^b   Fan, Wenpei ^b,c   Lin, Lisen ^b   Niu, Gang ^b   He, Nongyue ^a   Song, Jibin ^b   Chen, Xiaoyuan ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c Shenzhen University School of Medicine   (China)

^d GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

chemotherapy; light responsive; mPEG PLGA; multidrug resistance (MDR); nitric oxide (NO)

Indexed keywords

BIOCOMPATIBILITY; CHEMOTHERAPY; MOTION PICTURE EXPERTS GROUP STANDARDS; NITRIC OXIDE;

CHEMO SENSITIZATIONS; GAS MOLECULES; MPEG-PLGA; MULTIDRUG RESISTANCE; PHYSIOLOGICAL CONDITION; POLY LACTIC-CO-GLYCOLIC ACID; STIMULI-RESPONSIVE; VISIBLE IRRADIATION;

MEDICAL NANOTECHNOLOGY;

DOXORUBICIN; MACROGOL; NANOPARTICLE; NITRIC OXIDE;

CHEMISTRY; DRUG EFFECT; HUMAN; LIGHT; MULTIDRUG RESISTANCE; NANOMEDICINE; NEOPLASM; PROCEDURES; RADIATION RESPONSE; TUMOR CELL LINE;

CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; LIGHT; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; NITRIC OXIDE; POLYETHYLENE GLYCOLS;

EID: 84973596565     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.6b03737     Document Type: Article

References (32)

1. Persidis, A. Cancer Multidrug Resistance Nat. Biotechnol. 1999, 17 (1) 94-95 10.1038/5289
2. Grandjean, F.; Brémaud, L.; Verdier, M.; Robert, J.; Ratinaud, M.-H. Sequential Gene Expression of P-glycoprotein (P-gp), Multidrug Resistance-Associated Protein (MRP) and Lung Resistance Protein: Functional Activity of P-gp and MRP Present in the Doxorubicin-Resistant Human K562 Cell Lines Anti-Cancer Drugs 2001, 12 (3) 247-258 10.1097/00001813-200103000-00010
3. Nakanishi, T.; Ross, D. D. Breast Cancer Resistance Protein (BCRP/ABCG2): Its Role in Multidrug Resistance and Regulation of Its Gene Expression Aizheng 2012, 31 (2) 73 10.5732/cjc.011.10320
4. Ueda, K.; Clark, D.; Chen, C.; Roninson, I.; Gottesman, M.; Pastan, I. The Human Multidrug Resistance (mdr1) Gene. cDNA Cloning and Transcription Initiation J. Biol. Chem. 1987, 262 (2) 505-508
5. Taniguchi, K.; Wada, M.; Kohno, K.; Nakamura, T.; Kawabe, T.; Kawakami, M.; Kagotani, K.; Okumura, K.; Akiyama, S.-i.; Kuwano, M. A Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene is Overexpressed in Cisplatin-Resistant Human Cancer Cell Lines with Decreased Drug Accumulation Cancer Res. 1996, 56 (18) 4124-4129
6. Schroeijers, A. B.; Scheffer, G. L.; Flens, M. J.; Meijer, G. A.; Izquierdo, M. A.; Van Der Valk, P.; Scheper, R. J. Immunohistochemical Detection of the Human Major Vault Protein LRP with Two Monoclonal Antibodies in Formalin-Fixed, Paraffin-Embedded Tissues Am. J. Pathol. 1998, 152 (2) 373
7. Comerford, K. M.; Wallace, T. J.; Karhausen, J.; Louis, N. A.; Montalto, M. C.; Colgan, S. P. Hypoxia-Inducible Factor-1-Dependent Regulation of the Multidrug Resistance (MDR1) Gene Cancer Res. 2002, 62 (12) 3387-3394
8. Brown, J. M.; Wilson, W. R. Exploiting Tumour Hypoxia in Cancer Treatment Nat. Rev. Cancer 2004, 4 (6) 437-447 10.1038/nrc1367
9. Frederiksen, L. J.; Sullivan, R.; Maxwell, L. R.; Macdonald-Goodfellow, S. K.; Adams, M. A.; Bennett, B. M.; Siemens, D. R.; Graham, C. H. Chemosensitization of Cancer in vitro and in vivo by Nitric Oxide Signaling Clin. Cancer Res. 2007, 13 (7) 2199-2206 10.1158/1078-0432.CCR-06-1807
10. Matthews, N. E.; Adams, M. A.; Maxwell, L. R.; Gofton, T. E.; Graham, C. H. Nitric Oxide-Mediated Regulation of Chemosensitivity in Cancer Cells J. Natl. Cancer Inst. 2001, 93 (24) 1879-1885 10.1093/jnci/93.24.1879
11. Sullivan, R.; Graham, C. H. Hypoxia-Driven Selection of the Metastatic Phenotype Cancer Metastasis Rev. 2007, 26 (2) 319-331 10.1007/s10555-007-9062-2
12. Liao, D.; Johnson, R. S. Hypoxia: A Key Regulator of Angiogenesis in Cancer Cancer Metastasis Rev. 2007, 26 (2) 281-290 10.1007/s10555-007-9066-y
13. Pelicano, H.; Carney, D.; Huang, P. ROS Stress in Cancer Cells and Therapeutic Implications Drug Resist. Updates 2004, 7 (2) 97-110 10.1016/j.drup.2004.01.004
14. Brizel, D. M.; Sibley, G. S.; Prosnitz, L. R.; Scher, R. L.; Dewhirst, M. W. Tumor Hypoxia Adversely Affects the Prognosis of Carcinoma of the Head and Neck Int. J. Radiat. Oncol., Biol., Phys. 1997, 38 (2) 285-289 10.1016/S0360-3016(97)00101-6
15. Höckel, M.; Schlenger, K.; Aral, B.; Mitze, M.; Schäffer, U.; Vaupel, P. Association Between Tumor Hypoxia and Malignant Progression in Advanced Cancer of the Uterine Cervix Cancer Res. 1996, 56 (19) 4509-4515
16. Movsas, B.; Chapman, J. D.; Horwitz, E. M.; Pinover, W. H.; Greenberg, R. E.; Hanlon, A. L.; Iyer, R.; Hanks, G. E. Hypoxic Regions Exist in Human Prostate Carcinoma Urology 1999, 53 (1) 11-18 10.1016/S0090-4295(98)00500-7
17. Muir, C.; Adams, M.; Graham, C. Nitric Oxide Attenuates Resistance to Doxorubicin in Three-Dimensional Aggregates of Human Breast Carcinoma Cells Breast Cancer Res. Treat. 2006, 96 (2) 169-176 10.1007/s10549-005-9076-9
18. Ren, Z.; Gu, X.; Lu, B.; Chen, Y.; Chen, G.; Feng, J.; Lin, J.; Zhang, Y.; Peng, H. Anticancer Efficacy of A Nitric Oxide-Modified Derivative of Bifendate Against Multidrug-Resistant Cancer Cells J. Cell. Mol. Med. 2016, 1 10.1111/jcmm.12796
19. Prasad, V. R.; Reddy, G. D.; Kathmann, I.; Amareswararao, M.; Peters, G. Nitric oxide Releasing Acridone Carboxamide Derivatives as Reverters of Doxorubicin Resistance in MCF7/Dx Cancer Cells Bioorg. Chem. 2016, 64, 51-58 10.1016/j.bioorg.2015.11.007
20. Zhang, X.; Tian, G.; Yin, W.; Wang, L.; Zheng, X.; Yan, L.; Li, J.; Su, H.; Chen, C.; Gu, Z. Controllable Generation of Nitric Oxide by Near-Infrared-Sensitized Upconversion Nanoparticles for Tumor Therapy Adv. Funct. Mater. 2015, 25 (20) 3049-3056 10.1002/adfm.201404402
21. Rapozzi, V.; Della Pietra, E.; Bonavida, B. Dual Roles of Nitric Oxide in The Regulation of Tumor Cell Response and Resistance to Photodynamic Therapy Redox Biol. 2015, 6, 311-317 10.1016/j.redox.2015.07.015
22. Wink, D. A.; Miranda, K. M.; Espey, M. G.; Pluta, R. M.; Hewett, S. J.; Colton, C.; Vitek, M.; Feelisch, M.; Grisham, M. B. Mechanisms of the Antioxidant Effects of Nitric Oxide Antioxid. Redox Signaling 2001, 3 (2) 203-213 10.1089/152308601300185179
23. Cole, S. P.; Deeley, R. G. Transport of Glutathione and Glutathione Conjugates by MRP1 Trends Pharmacol. Sci. 2006, 27 (8) 438-446 10.1016/j.tips.2006.06.008
24. Lando, D.; Peet, D. J.; Whelan, D. A.; Gorman, J. J.; Whitelaw, M. L. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch Science 2002, 295 (5556) 858-861 10.1126/science.1068592
25. Zhu, H.; Bunn, H. F. Oxygen Sensing and Signaling: Impact on the Regulation of Physiologically Important Genes Respir. Physiol. 1999, 115 (2) 239-247 10.1016/S0034-5687(99)00024-9
26. Ridnour, L. A.; Isenberg, J. S.; Espey, M. G.; Thomas, D. D.; Roberts, D. D.; Wink, D. A. Nitric Oxide Regulates Angiogenesis Through a Functional Switch Involving Thrombospondin-1 Proc. Natl. Acad. Sci. U. S. A. 2005, 102 (37) 13147-13152 10.1073/pnas.0502979102
27. Samadi, N.; Abbadessa, A.; Di Stefano, A.; Van Nostrum, C.; Vermonden, T.; Rahimian, S.; Teunissen, E.; Van Steenbergen, M.; Amidi, M.; Hennink, W. The Effect of Lauryl Capping Group on Protein Release and Degradation of Poly (d, l-lactic-co-glycolic acid) Particles J. Controlled Release 2013, 172 (2) 436-443 10.1016/j.jconrel.2013.05.034
28. Fan, J.; He, N.; He, Q.; Liu, Y.; Ma, Y.; Fu, X.; Liu, Y.; Huang, P.; Chen, X. A Novel Self-Assembled Sandwich Nanomedicine for NIR-Responsive Release of NO Nanoscale 2015, 7 (47) 20055-20062 10.1039/C5NR06630A
29. Xue, Z.; Wu, Z.; Han, S. A Selective Fluorogenic Sensor for Visual Detection of Nitrite Anal. Methods 2012, 4 (7) 2021-2026 10.1039/c2ay25107h
30. Chung, M. F.; Liu, H. Y.; Lin, K. J.; Chia, W. T.; Sung, H. W. A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance Angew. Chem. 2015, 127 (34) 10028-10031 10.1002/ange.201504444
31. Yasuda, H.; Yamaya, M.; Nakayama, K.; Sasaki, T.; Ebihara, S.; Kanda, A.; Asada, M.; Inoue, D.; Suzuki, T.; Okazaki, T. Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin with Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non-Small-Cell Lung Cancer J. Clin. Oncol. 2006, 24 (4) 688-694 10.1200/JCO.2005.04.0436
32. Yasuda, H.; Nakayama, K.; Watanabe, M.; Suzuki, S.; Fuji, H.; Okinaga, S.; Kanda, A.; Zayasu, K.; Sasaki, T.; Asada, M. Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma Clin. Cancer Res. 2006, 12 (22) 6748-6757